Akoya Biosciences (AKYA)
(Delayed Data from NSDQ)
$3.85 USD
-0.06 (-1.53%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $3.86 +0.01 (0.26%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/13/24 |
---|---|
Current Quarter | -0.30 |
EPS Last Quarter | -0.22 |
Last EPS Surprise | 18.52% |
ABR | 1.28 |
Earnings ESP
|
-7.56% |
---|---|
Current Year | -0.86 |
Next Year | -0.50 |
EPS (TTM) | -1.48 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 24.13M | 27.71M | 115.48M | 137.73M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 24.94M | 28.70M | 116.28M | 140.40M |
Low Estimate | 22.55M | 26.00M | 115.00M | 134.60M |
Year ago Sales | 21.41M | 23.52M | 96.63M | 115.48M |
Year over Year Growth Est. | 12.69% | 17.79% | 19.50% | 19.27% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.30 | -0.26 | -0.86 | -0.50 |
# of Estimates | 4 | 4 | 5 | 5 |
Most Recent Consensus | -0.32 | -0.26 | -0.87 | -0.51 |
High Estimate | -0.27 | -0.22 | -0.80 | -0.49 |
Low Estimate | -0.32 | -0.30 | -0.90 | -0.51 |
Year ago EPS | -0.49 | -0.51 | -1.43 | -0.86 |
Year over Year Growth Est. | 38.78% | 49.02% | 39.86% | 41.86% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 0 | 1 | 3 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 0 |
Down Last 60 Days | 2 | 1 | 2 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.30 | -0.26 | -0.86 | -0.50 |
7 Days Ago | -0.29 | -0.25 | -0.86 | -0.50 |
30 Days Ago | -0.29 | -0.25 | -0.86 | -0.50 |
60 Days Ago | -0.26 | -0.25 | -0.90 | -0.62 |
90 Days Ago | -0.26 | -0.25 | -0.92 | -0.62 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.32 | -0.26 | -0.84 | -0.50 |
Zacks Consensus Estimate | -0.30 | -0.26 | -0.86 | -0.50 |
Earnings ESP | -7.56% | -1.96% | 2.68% | -0.40% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.22 | -0.26 | -0.51 | -0.49 | NA |
Estimate | -0.27 | -0.37 | -0.44 | -0.46 | NA |
Difference | 0.05 | 0.11 | -0.07 | -0.03 | 0.02 |
Surprise | 18.52% | 29.73% | -15.91% | -6.52% | 6.46% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more